tiprankstipranks
Entheon Biomedical (TSE:ENBI)
:ENBI
Canadian Market
ENBI
Entheon Biomedical
RESEARCH TOOLSreports

Entheon Biomedical (ENBI) Income Statement

16 Followers

Entheon Biomedical Income Statement

Last quarter (Q4 2025), Entheon Biomedical's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Entheon Biomedical's net income was C$-65.01K. See Entheon Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 25Feb 25Feb 24Feb 23Feb 22
Total Revenue
C$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 21.67K
Gross Profit
C$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 9.13K
Operating Expenses
C$ 334.22KC$ 332.66KC$ 564.32KC$ 3.79MC$ 8.21M
Depreciation and Amortization
C$ 0.00C$ 332.66KC$ 313.99KC$ 2.10KC$ 3.84K
EBITDA
C$ -334.22KC$ -318.00KC$ 13.99KC$ -3.60MC$ -8.21M
Operating Income
C$ -334.22KC$ -333.00KC$ -313.00KC$ -3.60MC$ -8.21M
Other Income/Expenses
C$ 10.21KC$ 14.74KC$ 12.81KC$ 1.54MC$ 215.87K
Pretax Income
C$ -324.01KC$ -318.00KC$ -300.00KC$ -2.06MC$ -8.00M
Net Income
C$ -324.01KC$ -318.00KC$ -300.00KC$ -8.52MC$ -8.89M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.04C$ -0.05C$ -0.14C$ -0.16
Diluted EPS
C$ -0.02C$ -0.04C$ -0.05C$ -0.14C$ -0.16
Weighted Average Shares Outstanding
 13.41M 7.74M 5.91M 59.09M 56.83M
Weighted Average Shares Outstanding (Diluted)
 13.41M 7.74M 5.91M 59.09M 56.87M
Currency in CAD

Entheon Biomedical Earnings and Revenue History